Anbio Biotechnology Class A Ordinary Shares Working Capital to Net Assets Ratio
Anbio Biotechnology Class A Ordinary Shares working capital to net assets ratio. Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Working Capital to Net Assets ratio of 100.0% as of March 2026. Working capital of $30.16 Million (current assets of $30.24 Million minus current liabilities of $87.84K) is measured against net assets of $30.16 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Anbio Biotechnology Class A Ordinary Sha's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Anbio Biotechnology Class A Ordinary Shares (2021–2025)
Working capital to net assets ratio of Anbio Biotechnology Class A Ordinary Shares from 2021 to 2025. This chart shows how Anbio Biotechnology Class A Ordinary Shares's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting working capital of $30.16 Million against net assets of $30.16 Million USD. See NNNN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Anbio Biotechnology Class A Ordinary Shares Working Capital to Net Assets Ratio by Year (2021–2025)
Anbio Biotechnology Class A Ordinary Shares working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Anbio Biotechnology Class A Ordinary Shares from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Anbio Biotechnology Class A Ordinary Sha's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.0% | $30.16 Million | $30.16 Million | $30.24 Million | $87.84K | ▲ +2.3 pp |
| 2024 | 97.7% | $16.80 Million | $17.19 Million | $18.53 Million | $1.73 Million | ▼ -1.8 pp |
| 2023 | 99.6% | $14.76 Million | $14.82 Million | $15.75 Million | $993.06K | ▼ -0.3 pp |
| 2022 | 99.9% | $12.53 Million | $12.55 Million | $13.94 Million | $1.41 Million | ▼ -0.1 pp |
| 2021 | 100.0% | $2.54 Million | $2.54 Million | $4.92 Million | $2.38 Million | — |